Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Clinical nutrition

Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trial



Pemphigus vulgaris (PV), as an autoimmune disease including mucosa and the skin, is associated with several complications and comorbidities. The present study planned to determine the effect of L-carnitine (LC) supplementation on biomarkers of oxidative stress (OS), antioxidant capacity and lipid profile in PV patients.


Fifty two control and patients with PV, participated in the current randomized, double-blind, placebo-controlled clinical trial. The patients were allocated randomly to receive 2 g per day LC tartrate subdivided into two equal doses of 1 g before breakfast and dinner (n=26) or placebo (n=26) for 8 weeks. Anthropometric, lipid profile and OS values were determined at baseline and end of intervention period.


LC intake significantly reduced serum levels of triglycerides, total-, LDL- cholesterol and oxidative stress index (OSI; P<0.05). In addition, supplementation with LC resulted to a meaningful increase in levels of total antioxidant capacity (TAC) (P=0.05) and serum carnitine (P<0.001). LC intake revealed non-significant change in serum total oxidant capacity (P=0.15) and HDL- cholesterol (P=0.06) in comparison to the placebo.


LC consumption may have favorable results on TAC, OSI and lipid profiles in patients with PV. The results were in line with the idea that LC supplementation can be associated with positive effects on metabolic status and OS of patients with PV.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1


  1. 1

    Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Toosi S, Mortazavi H . Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. Arch Iran Med 2014; 17: 626.

    PubMed  Google Scholar 

  2. 2

    Yeh SW, Sami N, Ahmed RA . Treatment of pemphigus vulgaris: current and emerging options. Am J Dermatol 2005; 6: 327–342.

    Article  Google Scholar 

  3. 3

    Pozzilli C, Marinelli F, Romano S, Bagnato F . Corticosteroids treatment. J Neurol Sci 2004; 223: 47–51.

    CAS  Article  Google Scholar 

  4. 4

    Stanbury RM, Graham EM . Systemic corticosteroid therapy—side effects and their management. Br J Ophthalmol 1998; 82: 704–708.

    CAS  Article  Google Scholar 

  5. 5

    Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q . Role of carnitine in disease. Nutr Metab 2010; 7: 1.

    Article  Google Scholar 

  6. 6

    Johri AM, Heyland D, Hétu M-F, Crawford B, Spence J . Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies. Nutr Metab Cardiovasc Dis 2014; 24: 808–814.

    CAS  Article  Google Scholar 

  7. 7

    Zhang J-j, Wu Z-b, Cai Y-j, Ke B, Huang Y-j, Qiu C-p et al. L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. Nutr J 2014; 13: 1.

    Article  Google Scholar 

  8. 8

    Molfino A, Cascino A, Conte C, Ramaccini C, Fanelli FR, Laviano A . Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism. JPEN J Parenter Enteral Nutr 2010; 34: 295–299.

    CAS  Article  Google Scholar 

  9. 9

    Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk effects of acetyl-l-carnitine therapy. Hypertension 2009; 54: 567–574.

    CAS  Article  Google Scholar 

  10. 10

    Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M . L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr 2009; 89: 71–76.

    CAS  Article  Google Scholar 

  11. 11

    Malek Mahdavi A, Mahdavi R, Kolahi S . Effects of l-carnitine supplementation on serum inflammatory factors and matrix metalloproteinase enzymes in females with knee osteoarthritis: a randomized, double-blind, placebo-controlled pilot study. J Am Coll Nutr 2016; 35: 597–603.

    CAS  Article  Google Scholar 

  12. 12

    Nazıroğlu M, Yıldız K, Tamtürk B, Erturan İ, Flores-Arce M . Selenium and psoriasis. Biol Trace Elem Res 2012; 150: 3–9.

    Article  Google Scholar 

  13. 13

    Shah AA, Sinha AA . Oxidative stress and autoimmune skin disease. Eur J Dermatol 2013; 23: 5–13.

    CAS  PubMed  Google Scholar 

  14. 14

    Naziroğlu M, Gümral N . Modulator effects of L-carnitine and selenium on wireless devices (2.45 GHz)-induced oxidative stress and electroencephalography records in brain of rat. Int J Radiat Biol 2009; 85: 680–689.

    Article  Google Scholar 

  15. 15

    Javanbakht M, Djalali M, Daneshpazhooh M, Zarei M, Eshraghian M, Derakhshanian H et al. Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgaris. Clin Exp Biol 2015; 40: 313–317.

    CAS  Google Scholar 

  16. 16

    Yesilova Y, Ucmak D, Selek S, Dertlioğlu S, Sula B, Bozkus F et al. Oxidative stress index may play a key role in patients with pemphigus vulgaris. J Eur Acad Dermatol Vereol 2013; 27: 465–467.

    CAS  Article  Google Scholar 

  17. 17

    Cao Y, Qu H-j, Li P, Wang C-b, Wang L-x, Han Z-w . Single dose administration of L-carnitine improves antioxidant activities in healthy subjects. Tohoku J Exp Med 2011; 224: 209–213.

    CAS  Article  Google Scholar 

  18. 18

    Lee B-J, Lin J-S, Lin Y-C, Lin P-T . Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial. Nutr J 2014; 13: 1.

    Article  Google Scholar 

  19. 19

    Mihai S, Sitaru C . Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007; 11: 462–481.

    CAS  Article  Google Scholar 

  20. 20

    Harman K, Seed P, Gratian M, Bhogal B, Challacombe S, Black M . The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144: 775–780.

    CAS  Article  Google Scholar 

  21. 21

    Committee IR. Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)–Short and Long Forms (November 2005). 2006.

  22. 22

    Malaguarnera M, Gargante MP, Russo C, Antic T, Vacante M, Malaguarnera M et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis—a randomized and controlled clinical trial. Am J Gastroenter 2010; 105: 1338–1345.

    CAS  Article  Google Scholar 

  23. 23

    Gonzalez-Ortiz M, Hernandez-Gonzalez SO, Hernandez-Salazar E, Martinez-Abundis E . Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Ann Nutr Metab 2008; 52: 335–338.

    CAS  Article  Google Scholar 

  24. 24

    Mahdavi AM, Mahdavi R, Kolahi S, Zemestani M, Vatankhah A-M . l-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis. Nutr Res 2015; 35: 707–715.

    Article  Google Scholar 

  25. 25

    Villani RG, Gannon J, Self M, Rich PA . L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exercise Metab 2000; 10: 199–207.

    CAS  Article  Google Scholar 

  26. 26

    Samimi M, Jamilian M, Afshar Ebrahimi F, Rahimi M, Tajbakhsh B, Asemi Z . Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial. Clin Endocrinol 2015; 84: 851–857.

    Article  Google Scholar 

  27. 27

    Spagnoli LG, Orlandi A, Marino B, Mauriello A, De Angelis C, Ramacci MT . Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis 1995; 114: 29–44.

    CAS  Article  Google Scholar 

  28. 28

    Huang H, Song L, Zhang H, Zhang J, Zhao W . Influence of L-carnitine supplementation on serum lipid profile in hemodialysis patients: a systematic review and meta-analysis. Kidney Blood Pressure Res 2013; 38: 31–41.

    Article  Google Scholar 

  29. 29

    Erturan İ, Nazıroğlu M, Akkaya VB . Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study. Cell Biochem Funct 2012; 30: 552–557.

    CAS  Article  Google Scholar 

  30. 30

    Naziroğlu M, Kökçam I, ŞimşŞek H, Karakılçık A . Lipid peroxidation and antioxidants in plasma and red blood cells from patients with pemphigus vulgaris. J Basic Clin Physiol Pharmacol 2003; 14: 31–42.

    Article  Google Scholar 

  31. 31

    Bin Aleem S, Hussain MM, Farooq Y . Levo-carnitine reduces oxidative stress and improves contractile functions of fast muscles in type 2 diabetic rats. Iranian Biomed J 2013; 17: 29–35.

    CAS  Google Scholar 

  32. 32

    Fatouros IG, Douroudos I, Panagoutsos S, Pasadakis P, Nikolaidis MG, Chatzinikolaou A et al. Effects of L-carnitine on oxidative stress responses in patients with renal disease. Med Sci Sports Exercise 2010; 42: 1809–1818.

    CAS  Article  Google Scholar 

  33. 33

    Gülçin İ . Antioxidant and antiradical activities of L-carnitine. Life Sciences 2006; 78: 803–811.

    Article  Google Scholar 

  34. 34

    Korkmaz S, Erturan İ, Nazıroğlu M, Uğuz AC, Çiğ B, Övey İS . Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca2+ release and antioxidant system. J Membr Biol 2011; 244: 113–120.

    CAS  Article  Google Scholar 

  35. 35

    Nazıroğlu M, Şahin M, Çiğ B, Aykur M, Erturan İ, Ugan Y . Hypericum perforatum modulates apoptosis and calcium mobilization through voltage-gated and TRPM2 calcium channels in neutrophil of patients with Behcet’s disease. J Membr Biol 2014; 247: 253–262.

    Article  Google Scholar 

  36. 36

    Rani PJA, Panneerselvam C . Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats. The J Gerontol A Biol Sci Med Sci 2002; 57: B134–B137.

    Article  Google Scholar 

  37. 37

    Türker Y, Nazıroğlu M, Gümral N, Çelik Ö, Saygın M, Çömlekçi S et al. Selenium and L-carnitine reduce oxidative stress in the heart of rat induced by 2.45-GHz radiation from wireless devices. Biol Trace Elem Res 2011; 143: 1640–1650.

    Article  Google Scholar 

Download references


This work is a part of MSc thesis supported by by the grants from TUMS (No.28824). We are thankful to all patients who contributed dedicatedly in the study.

Author information



Corresponding author

Correspondence to M H Javanbakht.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mohammadi, H., Djalali, M., Daneshpazhooh, M. et al. Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 72, 99–104 (2018).

Download citation

Further reading


Quick links